Lin Wang1, Dianyuan Li2, Manzhen Sun3, Xiaoli Chen3, Hongfei Li4, Xudong Zhang4, Xiaofei Wang4, Ruipan Zheng4, Guowen Li4. 1. Radiotherapy Inpatient Ward II, The First Affiliated Hospital of Zhengzhou University, No. 1 Eastern Jianshe Road, Zhengzhou, 450052, Henan Province, China. linwang_zzu@163.com. 2. School of Basic Medical Sciences, Zhengzhou University, No. 100 Science Avenue, Zhengzhou, 450000, Henan Province, China. dianyuanli58@163.com. 3. School of Basic Medical Sciences, Zhengzhou University, No. 100 Science Avenue, Zhengzhou, 450000, Henan Province, China. 4. Radiotherapy Inpatient Ward II, The First Affiliated Hospital of Zhengzhou University, No. 1 Eastern Jianshe Road, Zhengzhou, 450052, Henan Province, China.
Abstract
BACKGROUND: The aim of our study was to observe and compare the curative effect of radiotherapy, chemotherapy, and combined radiotherapy and chemotherapy, as well as comprehensive treatment on superior vena cava syndrome (SVCS) caused by malignant etiology. METHODS: A total of 48 patients with malignant SVCS admitted to our hospital from 2015 to 2020 were selected in this study. According to the different treatment methods, they were divided into radiotherapy group (group 1, 10 cases), chemotherapy group (group 2, 8 cases), combined radiotherapy and chemotherapy group (group 3, 22 cases), and comprehensive treatment group (group 4, 8 cases). RESULTS: There were no significant differences in efficacy and side effects among the four groups (all P > 0.05). Group 4 (median survival time of 36 months) could provide longer survival time than groups 1, 2, and 3 (median survival time of 10 months, 13.5 months, and 12 months, respectively). CONCLUSIONS: For patients with severe symptoms or good prognosis, comprehensive treatment could be selected to improve the quality of life and prolong the survival period; for patients with mild symptoms, radiotherapy, chemotherapy, or combined radiotherapy and chemotherapy could also reduce the symptoms of SVCS and treat tumor lesions.
BACKGROUND: The aim of our study was to observe and compare the curative effect of radiotherapy, chemotherapy, and combined radiotherapy and chemotherapy, as well as comprehensive treatment on superior vena cava syndrome (SVCS) caused by malignant etiology. METHODS: A total of 48 patients with malignant SVCS admitted to our hospital from 2015 to 2020 were selected in this study. According to the different treatment methods, they were divided into radiotherapy group (group 1, 10 cases), chemotherapy group (group 2, 8 cases), combined radiotherapy and chemotherapy group (group 3, 22 cases), and comprehensive treatment group (group 4, 8 cases). RESULTS: There were no significant differences in efficacy and side effects among the four groups (all P > 0.05). Group 4 (median survival time of 36 months) could provide longer survival time than groups 1, 2, and 3 (median survival time of 10 months, 13.5 months, and 12 months, respectively). CONCLUSIONS: For patients with severe symptoms or good prognosis, comprehensive treatment could be selected to improve the quality of life and prolong the survival period; for patients with mild symptoms, radiotherapy, chemotherapy, or combined radiotherapy and chemotherapy could also reduce the symptoms of SVCS and treat tumor lesions.
Authors: Philipp M Lepper; Sebastian R Ott; Hanno Hoppe; Christian Schumann; Uz Stammberger; Antonio Bugalho; Steffen Frese; Michael Schmücking; Norbert M Blumstein; Nicolas Diehm; Robert Bals; Jürg Hamacher Journal: Respir Care Date: 2011-01-27 Impact factor: 2.258
Authors: Mannat Narang; Pranshu Mohindra; Mark Mishra; William Regine; Young Kwok Journal: Hematol Oncol Clin North Am Date: 2019-10-31 Impact factor: 3.722
Authors: Tamir Friedman; Keith B Quencer; Sirish A Kishore; Ronald S Winokur; David C Madoff Journal: Semin Intervent Radiol Date: 2017-12-14 Impact factor: 1.513